Sec Form 4 Filing - Daniel Christopher F @ Destination Maternity Corp - 2015-11-16

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Daniel Christopher F
2. Issuer Name and Ticker or Trading Symbol
Destination Maternity Corp [ DEST]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President
(Last) (First) (Middle)
C/O DESTINATION MATERNITY CORPORATION, 232 STRAWBRIDGE DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
11/16/2015
(Street)
MOORESTOWN, NJ08057
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/16/2015 F 359 ( 1 ) D $ 5.38 26,857 ( 2 ) ( 3 ) D
Common Stock 11/18/2015 F 167 ( 4 ) D $ 5.3 26,690 ( 2 ) ( 3 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 20.62 ( 5 ) 06/01/2021 Common Stock 24,000 24,000 D
Stock Options (Right to Buy) $ 14.51 ( 6 ) 11/18/2021 Common Stock 2,503 2,503 D
Stock Options (Right to Buy) $ 19.89 ( 7 ) 11/16/2022 Common Stock 8,712 8,712 D
Stock Options (Right to Buy) $ 30.5 ( 8 ) 12/04/2023 Common Stock 9,248 9,248 D
Stock Options (Right to Buy) $ 14.3 ( 9 ) 12/05/2024 Common Stock 102,265 102,265 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Daniel Christopher F
C/O DESTINATION MATERNITY CORPORATION
232 STRAWBRIDGE DRIVE
MOORESTOWN, NJ08057
President
Signatures
Christopher F. Daniel 11/18/2015
Signature of Reporting Person Date
Explanation of Responses:
( 1 )359 shares were surrendered to the Issuer to pay applicable tax withholdings on the November 16, 2015 vest of 1,178 shares from the November 16, 2012 grant of 4,713 shares.
( 2 )Includes 17,144 shares of unvested restricted stock. This includes 2,000 shares of unvested restricted stock from the June 1, 2011 grant of 10,000 shares, which shares vest in equal annual installments over a five (5) year period beginning on June 1, 2012, and 1,179 shares of unvested restricted stock from the November 16, 2012 grant of 4,713 shares, which shares vest in annual installments over a four (4) year period beginning on November 16, 2013 as follows: 1,178 shares vest on each of November 16, 2013, November 16, 2014, and November 16, 2015, and 1,179 shares vest on November 16, 2016. Continued in next footnote.
( 3 )Also includes 2,920 shares from the December 4, 2013 grant of 3,893 shares, which shares vest in four (4) annual installments beginning on December 4, 2014 as follows: 973 shares vest on each of December 4, 2014, December 4, 2015, and December 4, 2016, and 974 shares vest on December 4, 2017; and 11,045 shares of restricted stock issued to the Reporting Person by the Issuer on December 5, 2014, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,761 shares vest on each of December 5, 2015, December 5, 2016, and December 5, 2017, and 2,762 shares vest on December 5, 2018.
( 4 )167 shares were surrendered to the Issuer to pay applicable tax withholdings on the November 18, 2015 vest of 547 shares from the November 18, 2011 grant of 2,188 shares.
( 5 )On June 1, 2011, options to purchase 40,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on June 1, 2012. 16,000 of the remaining outstanding June 1, 2011 options are vested and 8,000 are unvested.
( 6 )On November 18, 2011, options to purchase 5,006 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 18, 2012 as follows: 1,251 options vest on each of November 18, 2012 and November 18, 2014, and 1,252 options vest on each of November 18, 2013 and November 18, 2015. All of the remaining outstanding November 18, 2011 options are vested.
( 7 )On November 16, 2012, options to purchase 11,615 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 16, 2013 as follows: 2,903 options vest on November 16, 2013, and 2,904 options vest on each of November 16, 2014, November 16, 2015, and November 16, 2016. 5,808 of the remaining outstanding November 16, 2012 options are vested and 2,904 are unvested.
( 8 )On December 4, 2013, options to purchase 9,248 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on December 4, 2014. 2,312 of the outstanding December 4, 2013 options are vested and 6,936 are unvested.
( 9 )On December 5, 2014, options to purchase 102,265 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on December 5, 2015 as follows: 25,566 options vest on each of December 5, 2015, December 5, 2016, and December 5, 2017, and 25,567 options vest on December 5, 2018. All December 5, 2014 options are unvested.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.